First Author: A.Azab Abdou EGYPT
Back to previous
To test validity of vitrectomy as a primary intervention for virgin eyes with diabetic macular edema (no previous laser, anti-VEGF,and no intraor postoperative TA) all cases was not a accompanied by cataract extraction. No other ocular or macular pathology was accepted in the study. Aim to proof that vitrectomy is non-inferior sustainable and more economic approach to manage cases of centre involving clinically significant macular edema
Management of centre involving macular edema is great economic challenges in developing countries
Inclusion criteria 20 eyes with centre involving macular edema more than 300micron exclusion criteria cases with previous cataract surgery within previous 6 months, cases undergone previous intravitreal injections, cases with vitreomacular traction, cases with proliferative diabetic retinopathy
Both CMT and BCVA were significantly improved The mean CMT changed from 576.80 ± 169.74 µm (range 393-1000) at base line to 306.20 ± 47.08 µm (range 245-443) at 6 months, (statistically significant). The mean BCVA (LogMAR) changed from 1.04 ± 0.17 (range 0.7 -1.3) at base to 0.74 ± 0.27 (range 0.3-1.3) at 6months (statistically significant).
Pars plana vitrectomy may have a role as a primary intervention for naive eyes with clinically significant macular edema